Not to be missed. Helen Hobbs, Joe Goldstein and Michael Brown. The story of the LDL receptor and FH Family Heart Foundation Josh Knowles Fatima Rodriguez National Lipid Association ASPC European Atherosclerosis Society International Atherosclerosis Society (IAS) UTSW Heart Cardiometabolic Health Congress

Help us celebrate Dr. Juliet Knowles, PhD, Assistant Professor of Neurology (Pediatric Neurology) and of Pediatrics, for her Seed Grant project, "Novel ketone-derived anticonvulsant agents for the treatment of childhood refractory epilepsy." neuroscience.stanford.edu/people/juliet-…

A pleasure to contribute to the inaugural Stanford University RAISE Health symposium, a convening forum from Stanford Medicine and Stanford HAI (the Institute for Human-Centered Artificial Intelligence). Great discussions on responsible AI for safe and equitable health.

Excited to co-chair this year’s #FamilyHeartSummit24! Join us and meet special guests Drs. Brown, Goldstein & Hobbs #KnowFH #KnowLpa familyheart.org/2024-family-he… Josh Knowles Christie Ballantyne All-star cast including Khurram Nasir Amit Khera Clyde Yancy, MD, MSc Nihar Desai MD MPH Katherine Wilemon

To understand why exercise is beneficial for our health, researchers at Stanford Medicine conducted nearly 10,000 measurements across 20 types of tissues, gaining deeper insights into the effects of exercise.

We are thrilled to announce our new Chair of the Stanford Department of Medicine, Dr. Euan Ashley euan ashley . We have a great future ahead!!! Dr. Ashley becomes Chair Sept 18th, 2024.

Troponin I regulates cardiac contraction and is a biomarker for cardiac injury. In Nature Cardiovascular Research, we describe an unexpected novel role for cardiac troponin I: Directly impacting mitochondrial functions by binding ATP synthase and exacerbating ischemic injury nature.com/articles/s4416…

JUST IN: Positive topline results from our Phase 3 BROOKLYN study of obicetrapib, our investigational CETP inhibitor, in patients with heterozygous familial hypercholesterolemia (HeFH). bit.ly/4c2qHfw

👏👏🍾 Kudos to NewAmsterdam Pharma Corporation on the exciting results of the BROOKLYN trial! Family Heart Foundation was pleased to help recruit for this important trial. ➡️ Great to have more safe and effective options on the way! #KnowFH Katherine Wilemon Josh Knowles Michael Davidson MD John Kastelein

StanfordCVFellowship Stanford Center for Digital Health well represented at #ASPC2024 Josh Knowles Shoa L. Clarke

We are just so thrilled to launch our new center website! Check out all the cool stuff we're doing in CV genetics at the Stanford Center for Inherited Cardiovascular Disease (#SCICD): med.stanford.edu/familyheart.ht…

🙏🏻🙏🏻 to Dr Sperling & HCPLive for a great preview of the 10th Family Heart Foundation Global Summit!👇🏻 Previewing the Family Heart Global Summit, with Laurence Sperling, MD hcplive.com/view/previewin… via @hcplive Katherine Wilemon Josh Knowles Seth J. Baum MD Casey Mulligan Walsh Courtney Riley MD

A functional genomic framework to elucidate novel causal... : Hepatology journals.lww.com/hep/abstract/9…. Thanks to Peter Saliba Gustafsson who showed amazing grit to get this work done spanning pandemic and two countries! Ivan Carcamo-Oribe Stanford Diabetes Research Karolinska Institutet AHA Research NIDDK

The Division of Comprehensive Neurology in the Department of Neurology at Stanford University seeks a board-eligible or board-certified Comprehensive Neurologist to join the Department. #StanfordJobs med.stanford.edu/neurology/jobs…

Insulin Resistance (IR) is a key factor in the 3 diseases that are likely to be the cause of your death: - Cardiovascular Disease - Cancer - Dementia IR is not causal. But a huge amplifier of risk. But how do you know if you have Insulin Resistance? Here's how 🧵👇 /1

Presented at #ESCardio: Among patients with transthyretin amyloidosis with cardiomyopathy, the risk of death from any cause and recurrent cardiovascular events was lower with vutrisiran treatment than with placebo. Full HELIOS-B trial results: nej.md/3X5nl5Q

Sorry deniers - Here is the editorial (CAPS are mine) that refutes everything you believe - "We need to be identifying more effective strategies [HOW ABOUT APOB] for lipid screening and lowering in this segment of the population [YOUNG ADULTS], and reducing health inequity by

Thanks Gladstone Institutes for this piece!! its a real honor to be part of the Emerging leader selected by the NAM!!!

Thank you, Angela Haupt and TIME for covering Familial Hypercholesterolemia and high Lipoprotein(a). Read the article and connect with us at the Family Heart Foundation (Family Heart Foundation). #KnowFH #KnowLpa #LDLSafeZone